Related Experiment Videos

MDMA: further evidence that its action in the medial prefrontal cortex is mediated by the serotonergic system

H S Pan1, R Y Wang

  • 1Department of Psychiatry and Behavioral Science, State University of New York, Stony Brook 11794.

Brain Research
|January 25, 1991
PubMed

Insights

Systemic administration of 3,4-methylenedioxymethamphetamine (MDMA) reduces neuronal activity in the medial prefrontal cortex. This effect is mediated by the serotonin system, specifically through 5-HT uptake mechanisms.

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • 3,4-methylenedioxymethamphetamine (MDMA) is a psychoactive drug with complex effects on the central nervous system.
  • The medial prefrontal cortex (mPFc) plays a crucial role in cognitive and emotional regulation.

Purpose of the Study:

  • To investigate the effects of MDMA on neuronal activity in the medial prefrontal cortex.
  • To elucidate the neurochemical mechanisms underlying MDMA's action in the mPFc.

Main Methods:

  • Systemic administration of MDMA to subjects.
  • Electrophysiological recording of neuronal firing rates in the mPFc.
  • Administration of selective serotonin and dopamine reuptake inhibitors prior to MDMA.

Main Results:

  • MDMA significantly suppressed the firing rates of most mPFc neurons.
  • (+)-MDMA mimicked this effect, while (-)-MDMA did not.
  • Fluoxetine, a 5-HT uptake blocker, prevented MDMA's suppressant action, whereas GBR 12909, a dopamine uptake blocker, did not.

Conclusions:

  • The serotonin (5-HT) system mediates the suppressant effects of MDMA on mPFc neuronal activity.
  • The findings highlight the role of 5-HT neurotransmission in MDMA's neuropharmacological profile.

Related Concept Videos